Drugs / Abivertinib
Abivertinib
also known as
AC0010 · AC0010MA · A-610MA · A610 · ABIVERTINIB MALEATE · Abivertinib maleate dihydrate · Ac0010 maleate dihydrate · ACEA-100610MA · +6 more
Small molecule targets BTK, EGFR via inhibition
Trials 13 · a red edge is where a trial was stopped
Evidence & citations 19 cited values
Every value below carries the sentence it was read from. 14 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Abivertinib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05361915 ↗ |
| Known as | A-610MA | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297865 ↗ |
| Known as | A610 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297865 ↗ |
| Known as | ABIVERTINIB MALEATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297865 ↗ |
| Known as | Abivertinib maleate dihydrate | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297865 ↗ |
| Known as | AC0010 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03300115 ↗ |
| Known as | Ac0010 maleate dihydrate | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297865 ↗ |
| Known as | AC0010MA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02448251 ↗ |
| Known as | ACEA-100610MA | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297865 ↗ |
| Known as | ACEA100610 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297865 ↗ |
| Known as | Avitinib | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297865 ↗ |
| Known as | Avitinib Maleate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03574402 ↗ |
| Known as | EX-ACEA-0010MA | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297865 ↗ |
| Known as | EX-ACEA0010 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297865 ↗ |
| Known as | STI-5656 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04528667 ↗ |
| Action | Inhibit | “selectively suppress the activities of EGFR tyrosine kinase phosphorylation” NCT02274337 ↗ |
| Modality | Small molecule | “AC0010 is a novel, potent, small molecule irreversible tyrosine kinase inhibitor (TKI)” NCT02330367 ↗ |
| Route | Oral | “oral AC0010” NCT02330367 ↗ |
| Target | EGFR | “selectively suppress the activities of EGFR tyrosine kinase phosphorylation” NCT02274337 ↗ |